Idelalisib
Medication
Idelalisib, sold under the brand name Zydelig, is a medication used to treat certain blood cancers. Idelalisib acts as a phosphoinositide 3-kinase inhibitor; more specifically, it blocks P110δ, the delta isoform of the enzyme phosphoinositide... Wikipedia
ATC code: L01EM01 (WHO)
Elimination half-life: 8.2 hours
Onset of action: Tmax = 1.5 hours
Other names: GS-1101, CAL-101
Pronunciation: /aɪˈdɛləlɪsɪb/; eye-DEL-ə-li-sib